Zolazepam

DB11555ExperimentalVet approvedSmall molecule

Zolazepam is a pyrazolodiazepinone derivative used as an anaesthetic in veterinary medicine. Zolazepam is typically used in combination with the NMDA antagonist tiletamine or the α2 adrenoceptor agonist xylazine. It... It is around four times the potency of diazepam but it is both water-soluble and un-ionized at physiological pH meaning that its onset is very fast.

Formula / weight: C₁₅H₁₅FN₄O · 286.31 g/mol (avg)
Code names: CI-716 · DEA No. 7295

Resolves to

Compound

UNIIG1R474U58UCAS31352-82-6ChEMBLCHEMBL2111144

Clinical / RWD

RxNorm1535252

Structure

InChIKeyGDSCFOSHSOWNDL-UHFFFAOYSA-NSMILESCN1N=C(C)C2=C1N(C)C(=O)CN=C2C1=CC=CC=C1F

What you can answer from here — as of September 12, 2026

666Drug interactionsStructured to mechanism, not free text

2Marketed productsAcross 1 country and 1 labeller

10+ReferencesStructured and connected to the statements they support

Which companies are running trials of Zolazepam, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account